- Home
- MLAB vs KMDA Comparison
MLAB vs KMDA Comparison
Compare MLAB & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLAB
- KMDA
- Stock Information
- Founded
- MLAB 1982
- KMDA 1990
- Country
- MLAB United States
- KMDA Israel
- Employees
- MLAB N/A
- KMDA N/A
- Industry
- MLAB Industrial Machinery/Components
- KMDA Biotechnology: Pharmaceutical Preparations
- Sector
- MLAB Industrials
- KMDA Health Care
- Exchange
- MLAB Nasdaq
- KMDA Nasdaq
- Market Cap
- MLAB 441.2M
- KMDA 398.5M
- IPO Year
- MLAB N/A
- KMDA N/A
- Fundamental
- Price
- MLAB $73.67
- KMDA $7.05
- Analyst Decision
- MLAB Hold
- KMDA Strong Buy
- Analyst Count
- MLAB 1
- KMDA 2
- Target Price
- MLAB $67.00
- KMDA $13.00
- AVG Volume (30 Days)
- MLAB 100.5K
- KMDA 65.3K
- Earning Date
- MLAB 11-06-2025
- KMDA 11-10-2025
- Dividend Yield
- MLAB 0.87%
- KMDA 2.86%
- EPS Growth
- MLAB N/A
- KMDA 30.41
- EPS
- MLAB N/A
- KMDA 0.35
- Revenue
- MLAB $245,255,000.00
- KMDA $174,787,000.00
- Revenue This Year
- MLAB $5.38
- KMDA $14.49
- Revenue Next Year
- MLAB $5.25
- KMDA $10.12
- P/E Ratio
- MLAB N/A
- KMDA $20.35
- Revenue Growth
- MLAB 7.39
- KMDA 10.36
- 52 Week Low
- MLAB $55.45
- KMDA $5.54
- 52 Week High
- MLAB $155.12
- KMDA $9.16
- Technical
- Relative Strength Index (RSI)
- MLAB 46.86
- KMDA 52.07
- Support Level
- MLAB $70.00
- KMDA $6.55
- Resistance Level
- MLAB $82.37
- KMDA $7.34
- Average True Range (ATR)
- MLAB 4.39
- KMDA 0.19
- MACD
- MLAB -0.25
- KMDA 0.03
- Stochastic Oscillator
- MLAB 29.18
- KMDA 55.70
About MLAB Mesa Laboratories Inc.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.